Boehringer Ingelheim announced today that it has launched clinical development of its firstinclass IL11 inhibitor antibody BI 765423 with a Phase 1 study NCT05658107 to assess the safety tolerability and pharmacokinetics in healthy volunteers.
Boehringer Ingelheim announced today that it has launched clinical development of its first-in-class IL-11 inhibitor antibody BI 765423 with a Phase 1 study (NCT05658107) to assess the safety, tolerability
In a world first, scientists at Duke-NUS Medical School, the National Heart Center Singapore (NHCS) and colleagues in Germany have shown that regenerative therapy to restore impaired kidney function may soon be a possibility, according to Medical Xpress
Duke-NUS and NHCS scientists first in the world to regenerate diseased kidney asiaresearchnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiaresearchnews.com Daily Mail and Mail on Sunday newspapers.
Duke-NUS & NHCS Regen Diseased Kidney: World First miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.